XCath has a total of 100 patents globally, out of which 51 have been granted. Of these 100 patents, more than 92% patents are active. South Korea is where XCath has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of XCath.
XCath founded in 2017, XCath is an innovative startup specializing in medical robotics, nanorobotics, and materials science. The company develops advanced endovascular robotic systems and steerable guidewires to treat critical conditions like cerebrovascular disorders. With campuses in Houston, Texas, and Pangyo, South Korea, XCath is dedicated to delivering cutting-edge healthcare solutions globally.
Do read about some of the most popular patents of XCath which have been covered by us in this article and also you can find XCath patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over XCath patent portfolio.
How many patents does XCath have?
XCath has a total of 100 patents globally. These patents belong to 8 unique patent families. Out of 100 patents, 92 patents are active.
How Many Patents did XCath File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | XCath Applications Filed | XCath Patents Granted |
| 2025 | – | 4 |
| 2024 | 9 | 19 |
| 2023 | 3 | 5 |
| 2022 | 19 | 5 |
| 2021 | 4 | 5 |
| 2020 | 5 | 13 |
| 2019 | 21 | – |
| 2018 | 39 | – |
How many XCath patents are Alive/Dead?
Worldwide Patents
How Many Patents did XCath File in Different Countries?
Countries in which XCath Filed Patents
| Country | Patents |
| Korea (South) | 14 |
| United States of America | 10 |
| Europe (EPO) | 9 |
| China | 9 |
| Brazil | 8 |
| Canada | 8 |
| Japan | 8 |
| Taiwan | 7 |
| Hong Kong (S.A.R.) | 7 |
| Mexico | 4 |
| Australia | 4 |
| Germany | 3 |
Where are Research Centres of XCath Patents Located?
10 Best XCath Patents
WO2019133438A1 is the most popular patent in the XCath portfolio. It has received 13 citations so far from companies like Auris Health & Siemens Healthcare.
Below is the list of 10 most cited patents of XCath:
| Publication Number | Citation Count |
| WO2019133438A1 | 13 |
| US11076924B2 | 12 |
| US20210236778A1 | 10 |
| US11229775B2 | 6 |
| US10835716B2 | 6 |
| KR102194582B1 | 2 |
| US12171958B2 | 1 |
| US12161822B2 | 1 |
| US20220362526A1 | 1 |
| US20220313962A1 | 1 |
What Percentage of XCath US Patent Applications were Granted?
XCath (Excluding its subsidiaries) has filed 8 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 3 have been granted leading to a grant rate of 75.0%.
Below are the key stats of XCath patent prosecution at the USPTO.
Which Law Firms are managing US Patents for XCath?
| Law Firm | Total Applications | Success Rate |
| Patterson Sheridan Llp | 8 | 75.00% |
What are XCath key innovation segments?
What Technologies are Covered by XCath?
The chart below distributes patents filed by XCath in different countries on the basis of the technology protected in patents. It also represents the markets where XCath thinks it’s important to protect particular technological inventions.
R&D Focus: How has XCath search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by XCath?
